Literature DB >> 19786966

LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes.

J Bassols1, J M Moreno-Navarrete, F Ortega, W Ricart, J M Fernandez-Real.   

Abstract

BACKGROUND: LIGHT (lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells) is a member of the tumor necrosis factor (TNF) family, primarily expressed in lymphocytes, which was associated with the induction of pro-inflammatory cytokines and alterations of lipid homeostasis in animal models. We aimed to analyze whether LIGHT has a role in the human obesity-associated inflammatory status.
METHODS: The association between circulating LIGHT concentrations and clinical variables was studied in 190 subjects with different degrees of obesity and glucose tolerance. The expression and release of 21 different cytokines, and the expression of genes involved in lipid metabolism were also evaluated after stimulation with LIGHT in cultured human differentiated adipocytes.
RESULTS: Serum LIGHT concentrations positively associated with body mass index (BMI), fat mass, glycated hemoglobin and fasting triglycerides, and negatively with high-density lipoprotein cholesterol. Circulating LIGHT concentrations were significantly increased in morbidly obese subjects and in patients with type 2 diabetes. LIGHT induced the secretion of several cytokines and upregulated the expression and secretion of interleukin-6 (IL-6), IL-8, Growth Regulated Oncogene (GRO) and monocyte chemotactic protein-1 (MCP-1). These observations were concomitant with the activation of nuclear factor (NF)-kappaB signalling in human differentiated adipocytes. LIGHT also upregulated the expression and synthesis of its own receptor (herpesvirus entry mediator (HVEM)) and decreased the expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and fatty acid synthase.
CONCLUSION: These data suggest that LIGHT may have a role in mediating chronic inflammation and alterations of lipid metabolism in obese subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786966     DOI: 10.1038/ijo.2009.199

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  5 in total

1.  Realigning the LIGHT signaling network to control dysregulated inflammation.

Authors:  Carl F Ware; Michael Croft; Garry A Neil
Journal:  J Exp Med       Date:  2022-05-23       Impact factor: 17.579

2.  Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation.

Authors:  Kari Otterdal; John Willy Haukeland; Arne Yndestad; Tuva B Dahl; Sverre Holm; Filip M Segers; Ivar P Gladhaug; Zbigniew Konopski; Jan Kristian Damås; Bente Halvorsen; Pål Aukrust
Journal:  Clin Transl Gastroenterol       Date:  2015-07-02       Impact factor: 4.488

3.  Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis.

Authors:  You Li; Ming Tang; Bo Han; Shun Wu; Shu-Jing Li; Qian-Hui He; Feng Xu; Gui-Qing Li; Kun Zhang; Xu Cao; Quan-You Zheng; Jian Chen; Di Yang; Gui-Lian Xu; Ke-Qin Zhang
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

Review 4.  The Adipocyte and Adaptive Immunity.

Authors:  Jianfeng Song; Tuo Deng
Journal:  Front Immunol       Date:  2020-11-27       Impact factor: 7.561

5.  Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome.

Authors:  Alen Lovric; Marit Granér; Elias Bjornson; Muhammad Arif; Rui Benfeitas; Kristofer Nyman; Marcus Ståhlman; Markku O Pentikäinen; Jesper Lundbom; Antti Hakkarainen; Reijo Sirén; Markku S Nieminen; Nina Lundbom; Kirsi Lauerma; Marja-Riitta Taskinen; Adil Mardinoglu; Jan Boren
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.